CLASS II Device recall · Reported 11 May 2016 · FDA Enforcement Report

HeartStart MRx Monitor/Defibrillator The HeartStart MRx recalled

Philips Electronics North America is recalling HeartStart MRx Monitor/Defibrillator The HeartStart MRx is for use for the termination of, distributed in California, North Carolina. The recall was initiated on 14 Apr 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUS00586611, US00589878, US00594232, US00588464, US00591080, US00594779, US00588657, US00592182, US00594913, US00589391, US00593861, US00595298, US00589472, US00594092, US00595443, US00589851, US00594168
Quantity recalled17

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1612-2016
FDA event ID
73825
Recalling firm
Philips Electronics North America, Andover, MA
Classification
Class II
Status
Terminated
Recall initiated
14 Apr 2016
FDA classified
5 May 2016
Reported
11 May 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

14 Apr 2016Recall initiated by company
5 May 2016Classified by FDA+21 days
11 May 2016Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

MRx monitor/defibrillators could fail to charge because the therapy printed circuit board may have been loaded with an incorrect electronic component.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

HeartStart MRx Monitor/Defibrillator The HeartStart MRx is for use for the termination of ventricular tachycardia and ventricular fibrillation. The device is for use by qualified medical personnel trained in the operation of the device and qualified by training in basic life support, advanced cardiac support, or defibrillation. It must be used by or on the order of a physician.

Where it was distributed

Worldwide Distribution - US including OH, CA, NC and Internationally to China, Iraq, Japan, and Korea.

CaliforniaNorth Carolina

Questions about this recall

Why was it recalled?

MRx monitor/defibrillators could fail to charge because the therapy printed circuit board may have been loaded with an incorrect electronic component.

Which lots are affected?

US00586611, US00589878, US00594232, US00588464, US00591080, US00594779, US00588657, US00592182, US00594913, US00589391, US00593861, US00595298, US00589472, US00594092, US00595443, US00589851, US00594168

Where was it sold?

Worldwide Distribution - US including OH, CA, NC and Internationally to China, Iraq, Japan, and Korea.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Philips Electronics North America

All 160

Other Pacemakers & Defibrillators recalls

All 494